The effect of ranitidine on long-term survival in primary colorectal cancer. A 40 months interim analysis

GI Cancer

Volumn 2, Issue 3, 1998, Pages 227-233

  Nielsen, H J ^a   McArdle, C S ^a   Moesgaard, F ^a   Schulze, S ^a   Thorup, J ^a   Wille Jorgensen, P ^a   Bentzen, E ^a   Christoffersen, I ^a   Moller, P ^a   Banke, L ^a   Froberg, D ^a   Henriksen, F W ^a   Crone, P ^a   Hesselfeldt, P ^a   Hempel Sparso, B ^a   Lindorff Larsen, K ^a   Asmussen, T ^a   Heiner, J ^a   Hart Hansen, O ^a   Flyger, H ^a   Jess, P ^a   Iversen, J ^a   La Cour Andersen, J ^a   Vennits, B ^a   Hansen, U ^a   Hammer, J ^a   Fischer, A ^a   Galatius, H ^a   Naver, L ^a   Teilum, D ^a   Svendsen, L B ^a   Vedel, L ^a   Holbraad, L ^a   Iversen, O ^a   Nymark, J ^a   Roikjor, O ^a   Palm, L ^a   Rasmussen, K C ^a   Friis, J ^a   Lanng, C ^a   Wiboltt, K ^a   Jensen, N C ^a   Hoffman, N ^a   Larsen, T ^a   Packler, J ^a   Simpson, C ^a   Morran, C ^a   Miller, D ^a   Smith, I ^a   Campbell, H ^a   more..

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Colorectal cancer; Histamine 2 receptor antagonists; Ranitidine; Survival

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 7144255544     PISSN: 10649700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)